One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1093/annonc/mdz260.112
Copy DOI
Export
Save
Share
Cite Journal: Annals of Oncology |  Publication Date: Oct 1, 2019 |
 License type: publisher-specific-oa |
Affiliation: City of Hope, Memorial Sloan Kettering Cancer Center, Stanford University, Huntsman Cancer Institute, Fox Chase Cancer Center, GlaxoSmithKline (United States), University of Chicago, UPMC Hillman Cancer Center, Princess Margaret Cancer Centre, Centre Hospitalier de l’Université de Montréal, Emory University, Duke University, University of California, Davis, MSD (United States), The Ohio State University Wexner Medical Center, James Cancer Hospital, Hospital Universitario Fundación Jiménez Díaz, University of California, San Diego, Tennessee Oncology
1590TiP - Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
